1. Home
  2. JFIN vs RCEL Comparison

JFIN vs RCEL Comparison

Compare JFIN & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JFIN
  • RCEL
  • Stock Information
  • Founded
  • JFIN 2011
  • RCEL N/A
  • Country
  • JFIN China
  • RCEL United States
  • Employees
  • JFIN N/A
  • RCEL N/A
  • Industry
  • JFIN Finance: Consumer Services
  • RCEL Medical/Dental Instruments
  • Sector
  • JFIN Finance
  • RCEL Health Care
  • Exchange
  • JFIN Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • JFIN 969.7M
  • RCEL 161.5M
  • IPO Year
  • JFIN 2019
  • RCEL N/A
  • Fundamental
  • Price
  • JFIN $16.17
  • RCEL $5.32
  • Analyst Decision
  • JFIN
  • RCEL Strong Buy
  • Analyst Count
  • JFIN 0
  • RCEL 4
  • Target Price
  • JFIN N/A
  • RCEL $16.50
  • AVG Volume (30 Days)
  • JFIN 200.1K
  • RCEL 323.0K
  • Earning Date
  • JFIN 06-04-2025
  • RCEL 08-07-2025
  • Dividend Yield
  • JFIN 4.96%
  • RCEL N/A
  • EPS Growth
  • JFIN 2.88
  • RCEL N/A
  • EPS
  • JFIN 3.43
  • RCEL N/A
  • Revenue
  • JFIN $840,800,386.00
  • RCEL $71,661,000.00
  • Revenue This Year
  • JFIN N/A
  • RCEL $57.16
  • Revenue Next Year
  • JFIN N/A
  • RCEL $36.69
  • P/E Ratio
  • JFIN $4.68
  • RCEL N/A
  • Revenue Growth
  • JFIN 4.83
  • RCEL 41.35
  • 52 Week Low
  • JFIN $4.00
  • RCEL $4.71
  • 52 Week High
  • JFIN $19.23
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • JFIN 51.77
  • RCEL 39.85
  • Support Level
  • JFIN $15.21
  • RCEL $4.71
  • Resistance Level
  • JFIN $17.32
  • RCEL $5.55
  • Average True Range (ATR)
  • JFIN 0.89
  • RCEL 0.29
  • MACD
  • JFIN -0.33
  • RCEL 0.08
  • Stochastic Oscillator
  • JFIN 20.15
  • RCEL 41.03

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: